Chemoinformaics analysis of Beta-Amino-Isobutyric-Acid
| Molecular Weight | 157.277 | nRot | 2 |
| Heavy Atom Molecular Weight | 150.221 | nRig | 1 |
| Exact Molecular Weight | 157.002 | nRing | 0 |
| Solubility: LogS | -1.007 | nHRing | 0 |
| Solubility: LogP | -2.879 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 25.1116 |
| nHD | 2 | BPOL | 15.0404 |
| QED | 0.488 |
| Synth | 5.074 |
| Natural Product Likeliness | 0.412 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.032 |
| HIA | 0.076 |
| CACO-2 | -6.317 |
| MDCK | 0.0233066 |
| BBB | 0.026 |
| PPB | 0.351136 |
| VDSS | 0.572 |
| FU | 0.493222 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.094 |
| CYP2c19-inh | 0.021 |
| CYP2c19-sub | 0.161 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.165 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.224 |
| CYP3a4-inh | 0.008 |
| CYP3a4-sub | 0.054 |
| CL | 1.821 |
| T12 | 0.733 |
| hERG | 0.003 |
| Ames | 0.904 |
| ROA | 0.161 |
| SkinSen | 0.213 |
| Carcinogencity | 0.973 |
| EI | 0.62 |
| Respiratory | 0.894 |
| NR-Aromatase | 0.001 |
| Antiviral | No |
| Prediction | 0.947917 |